步行节奏和心力衰竭之间的关联:孟德尔的随机化分析.
He Zheng1, Wenbin Wang2, Chaolei Chen2
1School of Medicine, South China University of Technology, Guangzhou, China; Department of Cardiology, Hypertension Research Laboratory, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.
Nutrition, metabolism, and cardiovascular diseases : NMCD
|August 22, 2024
概括
步行速度较慢表明心力衰竭 (HF) 的风险较高,这种关系是双向的. 管理腰部和部的比例,2型糖尿病和甘油三酸可以帮助预防高血压.
科学领域:
- 心血管遗传学 心血管遗传学
- 流行病学 流行病学
- 代谢疾病 代谢疾病
背景情况:
- 步行节奏和心力衰竭 (HF) 之间的联系是已知的,但因果途径和风险因素尚不清楚.
- 了解这种关系对于制定有效的HF预防策略至关重要.
研究的目的:
- 调查步行节奏和HF风险之间的双向因果关系.
- 确定步行节奏和高频率之间的关联中的潜在调解因素.
主要方法:
- 使用双向双样本的门德尔随机化 (MR) 与全基因组关联研究 (GWAS) 总结统计.
- 采用多变量门德尔随机化 (MVMR) 来探索介导因素.
- 用心力衰竭的独立GWAS数据验证的结果.
主要成果:
- 增加步行速度与降低HF风险相关 (OR,0.589).
- 腰与部比 (WHR),2型糖尿病和甘油三调节了这一效应的很大一部分.
- 基因预测的HF风险与步行速度较慢有关 (OR,0.975).
结论:
- 缓慢的步行速度和高高压风险之间存在双向因果关系.
- 针对WHR,2型糖尿病和甘油三的干预措施可以帮助缓慢步行者预防HF.
相关概念视频
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Genome-wide Association Studies-GWAS
13.2K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.2K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
405
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
405


